🇺🇸 FDA
Patent

US 10765745

Multifunctional nanoparticle systems and methods for cancer diagnosis and combination therapy

granted A61KA61K31/5377A61K31/7068

Quick answer

US patent 10765745 (Multifunctional nanoparticle systems and methods for cancer diagnosis and combination therapy) held by The Board of Regents of the University of Texas System expires Mon Sep 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Sep 08 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K31/5377, A61K31/7068, A61K33/243, A61K33/244